The human σ 1 receptor is an enigmatic endoplasmic-reticulumresident transmembrane protein implicated in a variety of disorders including depression, drug addiction, and neuropathic pain 1 . Recently, an additional connection to amyotrophic lateral sclerosis has emerged from studies of human genetics and mouse models 
. These receptors were divided into four classes based on their ligand-binding properties and tissue distribution, leading to the concept of μ (morphine), δ (vas deferens), κ (ketazocine), and σ (SKF-10047) opioid receptor subtypes. Pharmacological studies suggested μ, δ, and κ receptors were closely related to one another, while the σ receptor was shown to be distinct. Unlike canonical opioid receptors, the σ 1 receptor shows negligible affinity for naloxone and naltrexone. In addition, it exhibits a marked preference for the (+)-enantiomers of benzomorphan drugs while canonical opioid receptors bind with high affinity only to the (−)-enantiomers 4 . In 1996, the molecular cloning of the σ 1 receptor confirmed definitively that the receptor is dissimilar in sequence from the true opioid receptors 5 . The σ 1 receptor plays a key role in human physiology, and has been shown to modulate a variety of diseases of the cardiovascular and nervous system 6 . Of particular note, a point mutation in this receptor was identified as a cause of juvenile-onset amyotrophic lateral sclerosis in humans 7 , and mouse studies further support a role in the progression of this disease 8 . Other important research has suggested a role for the σ 1 receptor as an endoplasmicreticulum chaperone protein and regulator of calcium signalling 9 , and it has been reported to regulate the activity of various ion channels 10 and G-protein-coupled receptors 11 . Despite the increasingly apparent importance of the σ 1 receptor in human physiology, remarkably little is known about its structure and the details of its function at the molecular level. Even the overall topology of the receptor has remained in doubt, with single-pass 12 and two-pass 13 transmembrane architectures proposed. To address the gap in structural information surrounding the σ 1 receptor, we undertook biochemical and crystallographic studies to elucidate its structure in complex with two distinct ligands. A receptor construct bearing an amino (N)-terminal Flag tag was expressed in Sf9 insect cells and purified in detergent (Extended Data Fig. 1 ). Using lipidic cubic phase crystallization we obtained crystals and used experimental phasing with tantalum bromide clusters to solve a 2.5 Å resolution structure of the σ 1 receptor bound to PD144418, a high-affinity and selective σ 1 antagonist 14, 15 . A similar approach also enabled structure determination for σ 1 receptor bound to a second ligand 16 , 4-IBP, at 3.2 Å resolution (Extended Data  Table 1 and Extended Data Fig. 2 ). 4-IBP has an incompletely understood efficacy profile, with functional properties suggestive of either agonist or inverse agonist activity 17 . The overall structure of the σ 1 receptor reveals a trimeric organization with a threefold non-crystallographic symmetry axis normal to the membrane plane (Fig. 1a) . The receptor contains only a single transmembrane domain for each protomer, contrary to the prevailing models of a two-pass transmembrane architecture. The carboxy (C)-terminal membrane-adjacent domains mediate the trimeric structure of the receptor, packing closely together with an interface of ~9,300 Å 2 between each adjacent pair of protomers. In contrast, the three transmembrane helices are widely separated from one another, located at each corner of the triangular trimer where they mediate lattice contacts (Extended Data Fig. 3 ). The membrane-proximal side of the cytosolic domains is an extremely flat hydrophobic surface, which is probably embedded within the membrane plane (Fig. 1b and Extended Data Fig. 4 ). The cytosolic domain of each of the three protomers shows a β-barrel fold with the ligand at its centre, flanked by four α-helices (Fig. 2) . The ligand-binding domain is highly conserved in sequence across species, as is the intermolecular interface among the three protomers (Extended Data Figs 5 and 6). The overall fold of the β-barrel ligand-binding region closely resembles that of cupin family proteins, most of which are oligomeric bacterial enzymes (Extended Data Table 2 ). While there is no obvious functional similarity between such proteins and the σ 1 receptor, the enzyme catalytic sites are generally synonymous with the ligand-binding site of the σ 1 receptor, suggesting the σ 1 receptor may represent a repurposed enzyme in which the catalytic site inside the β-barrel has been co-opted as a ligand-binding site.
Recently, a mutation in the σ 1 receptor, E102Q, was identified as a cause of inherited juvenile-onset amyotrophic lateral sclerosis in a family in eastern Saudi Arabia 7 . Cell biological experiments have shown that this receptor mutant is prone to aggregation, leading to mislocalization of TDP43 and consequent cytoxicity 18 . The structures reported here offer an explanation for the phenotype of this mutant. The highly conserved Glu102 is deeply buried, with its carboxyl oxygen atoms each accepting a hydrogen bond from the backbone amides of Val36 and Phe37, which are part of a structured tether between the transmembrane domain and cytosolic domain (Fig. 2c) . Mutation of Glu to Gln would block this interaction, converting one of the two favourable LETTER RESEARCH hydrogen bond interactions into an energetically unfavourable juxtaposition of hydrogen bond donors, accounting for the previously observed receptor destabilization.
One of the most intriguing features of the σ 1 receptor is the remarkable diversity of the ligands to which it binds. These include a multitude of biologically active compounds targeted at other receptors, such as dextromethorphan (inhibition constant K i = 200 nM) 19 , haloperidol (K i = 1.1 nM), fluoxetine (K i = 1.9 μM), quetiapine (K i = 220 nM), clemastine (K i = 67 nM), and chloroquine (K i = 109 nM), among many others (affinities are from the PDSP K i Database 20 unless otherwise noted). These ligands are diverse in chemical structure, sharing few common features with the exception of a cationic amine and at least one aromatic ring. To understand the molecular basis for this ligand-binding promiscuity, we performed additional crystallization and structure determination experiments with receptor bound to the ligand 4-IBP. The two ligands, 4-IBP and PD144418, were selected in part on the basis of their divergence in chemical structure, with a Tanimoto similarity coefficient of 0.235, indicating no substantial structural similarity. Nonetheless, it should be noted that both compounds are positively charged, elongated molecules with substantial hydrophobic character-all common features among σ 1 receptor ligands.
In comparing the two structures, very little deviation is seen in receptor conformation, and the all-atom root mean squared deviation for the two structures is 0.4 Å. The two ligands bind in similar positions (Extended Data Fig. 7 ), in each case interacting with the receptor through a charge-charge interaction with the highly conserved Glu172, consistent with previous mutagenesis experiments identifying this residue as essential for ligand binding 21 . A second essential acidic residue, Asp126, forms a 2.7 Å hydrogen bond with Glu172, indicating it is probably protonated at least when ligands are bound. With the exception of these two amino acids, the binding pocket overall is very hydrophobic and its interior is completely occluded from solvent ( Fig. 3a) . Other residues in the binding site include Val84, Trp89, Met93, Leu95, Leu105, Phe107, Ile124, Trp164, and Leu182, which interact with hydrophobic regions on the bound ligands, and Tyr103, which engages in an aromatic stacking interaction in both structures (Fig. 3b, c) . In addition, Tyr103 makes a hydrogen bond to Glu172, accounting for a fivefold reduction in binding affinity to (+)-pentazocine in a Y103F mutant 22 . Given the highly occluded structure of the binding pocket, it remains unclear how ligands enter and exit this site. Two possibilities are apparent: ligands could enter and exit through a gap between the two membrane-adjacent helices, directly into/out of the plasma membrane, or they could access the binding site through the cytosolic surface, passing through a polar region occluded by Gln135, Glu158, and His154. Since both potential points of entry/egress are in a closed conformation in To better understand σ 1 receptor oligomerization, we performed size-exclusion chromatography with multi-angle light scattering (SEC-MALS) experiments as well as native polyacrylamide gel electrophoresis (PAGE) analysis. Samples in SEC-MALS showed a single sharp peak of protein, but light scattering and refractive index analysis revealed that this peak comprises protein species ranging in molecular mass from at least 140 kDa (excluding detergent mass) to about 400 kDa. This suggests the presence of oligomers ranging in size from hexamers to as large as 15-mers (Extended Data Fig. 8a, b) . Native PAGE experiments showed similar results, again revealing a polydisperse mixture of high molecular mass oligomers (Extended Data Fig. 8c) . These experiments in pure detergents showed little difference between agonist-and antagonist-bound receptor. In contrast, size exclusion in a mixed micelle of maltose neopentyl glycol detergent with cholesterol hemisuccinate showed modest differences in SEC profile (Extended Data Fig. 8d) , with agonists partly disrupting high-order oligomers. It is important to note that our results in detergent may not fully recapitulate receptor behaviour in vivo; however, taken together with the previously reported biochemical and cellular studies, these data suggest oligomerization is a key functional property of the σ 1 receptor and may be linked to ligand efficacy.
In summary, the results presented here show for the first time the overall molecular structure of the σ 1 receptor, an important but poorly understood human transmembrane receptor. The structure reveals the basis for receptor oligomerization and ligand binding, and moreover
shows an unexpected single-pass transmembrane topology. These results now offer a solid foundation for the development of future biochemical and biophysical studies towards understanding the σ 1 receptor at the molecular level.
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METHODS
Expression and purification. The human σ 1 receptor was cloned into pFastbac1 with an N-terminal haemagglutinin signal sequence followed by a Flag epitope tag and a 3C protease cleavage site. After proteolytic digest to remove the Flag tag, the resulting protein is identical to the wild-type receptor with the exception of an N-terminal protease site scar, comprising the sequence 'GPGS' . This receptor construct was expressed in Sf9 insect cells (Expression Systems) using the FastBac baculovirus system (ThermoFisher) according to the manufacturer's instructions. Infection was performed when cells reached a density of 4 × 10 6 cells per millilitre, and flasks were shaken at 27 °C for 2 days before harvest.
Cells were harvested by centrifugation and frozen at −80 °C until purification. For both PD144418 and 4-IBP-bound receptors, 1 μM of ligand was added in all purification steps. After thawing frozen cell paste, cells were lysed by osmotic shock in 20 mM HEPES pH 7.5, 2 mM magnesium chloride, and 1:100,000 (v:v) benzonase nuclease (Sigma Aldrich). Lysed cells were centrifuged at 47,800g in a Sorvall RC 5C Plus centrifuge with an SS-34 rotor for 15 min. The receptor was then extracted using a glass dounce tissue grinder in a solubilization buffer containing 250 mM NaCl, 20 mM HEPES pH 7.5, 20% (v/v) glycerol, 1% (w/v) lauryl maltose neopentyl glycol (LMNG; Anatrace), and 0.1% (w/v) cholesterol hemisuccinate (CHS; Steraloids). Samples were stirred for 2 h at 4 °C, then centrifuged as before for 20 min. Next, samples were filtered on a glass microfibre filter. The filtered supernatant containing solubilized receptor was supplemented with 2 mM calcium chloride and loaded by gravity flow onto 5 ml anti-Flag antibody affinity resin. The resin was washed extensively, first in 50 ml of buffer containing 100 mM NaCl, 20 mM HEPES pH 7.5, 2 mM calcium chloride, 0.2% glycerol, 0.1% LMNG, and 0.01% CHS, and then in 50 ml of buffer containing 100 mM NaCl, 20 mM HEPES pH 7.5, 2 mM calcium chloride, 0.02% glycerol, 0.01% LMNG, and 0.001% CHS. The receptor was eluted in the same buffer supplemented with 5 mM EDTA and 0.2 mg ml −1 Flag peptide in lieu of calcium. 3C protease was added (1:100 w:w) and incubated with the receptor at 4 °C overnight.
The receptor was further purified by SEC on a Sephadex S200 column (GE Healthcare) in buffer containing 0.01% LMNG, 0.001% CHS, 100 mM NaCl, 20 mM HEPES pH 7.5, and 1 μM of ligand. The receptor was biochemically pure but consistently ran as a high molecular mass oligomer during SEC. After preparative SEC, the protein was concentrated to 20-30 mg ml −1 and flash frozen with liquid nitrogen in aliquots of 8-9 μl. Samples were stored at −80 °C until use for crystallography. Purity and monodispersity of crystallographic samples was evaluated by SDS-PAGE and analytical SEC, respectively (Extended Data Fig. 1 ). Crystallography and data collection. Purified σ 1 receptor was reconstituted into lipidic cubic phase by mixing with a 10:1 (w:w) mix of monoolein (Hampton Research) with cholesterol (Sigma Aldrich) at a ratio of 1.5:1.0 lipid:protein by mass, using the coupled syringe reconstitution method 31 . All samples were mixed at least 100 times. The resulting phase was dispensed in 30-40 nl drops onto either a glass plate or a hanging drop cover, and overlaid with 600 nl of precipitant solution using a Gryphon LCP robot (Art Robbins Instruments). Crystals grew in precipitant solution containing 40-50% PEG 300, 220-250 mM LiSO 4 , 0.1 M MES pH 6.5. Initial crystallization hits grew slowly, with crystals reaching full size over the course of 2-4 weeks. Crystals were harvested using mesh loops and stored in liquid nitrogen until data collection.
Data collection was performed at Advanced Photon Source GM/CA beamlines 23ID-B and 23ID-D (native data), and at NE-CAT beamline 24ID-C (tantalum bromide derivative). An initial grid raster with 80 μm × 30 μm beam dimensions was performed using a 20 μm beam to locate crystals in the loop. Additional rasters were performed using a 10 μm beam diameter to optimally position the crystal for data collection. Data collection used a 10 μm beam and diffraction images were collected in 0.2-1° oscillations at a wavelength of 1.033 Å. For σ 1 bound to PD144418, a complete data set was obtained from a single crystal. For σ 1 bound to 4-IBP, a complete data set was the result of merging data from three crystals. Experimental phasing and structure refinement. To obtain phases, crystals of σ 1 receptor bound to PD144418 were grown using a hanging-drop lipidic cubic phase methodology adapted from a previous report 32 . In brief, this entailed dispensing cubic phase drops onto a plastic cover film (Art Robbins Instruments) and overlaying with precipitant solution as described above. This film was then inverted over a matched plate with identical crystallization solutions to the precipitant surrounding the lipid drop. The resulting crystals could be soaked and resealed, unlike conventional glass sandwich lipidic cubic phase plates. Crystals prepared in this way were soaked with tantalum bromide clusters for approximately 12 h by adding crushed granules of tantalum bromide clusters to the edge of the well. The crystals were harvested and data collected as described above, but at a wavelength of 1.2548 Å.
Initial phases were obtained in SHARP 33 using single isomorphous replacement and anomalous scattering. Three transmembrane α-helices were identifiable in the initial map, suggesting three molecules in the asymmetric unit with an unusual solvent content of ~70%. Experimental phases were iteratively combined with model-derived phase to improve the electron density map through solvent flattening in SHARP. Model building was performed in Coot 34 , and refinement was performed in phenix.refine 35 . All three chains are highly similar in structure, with all-atom pairwise root mean squared deviation of cytosolic domains ranging from 0.22 Å to 0.26 Å, while the orientation of the transmembrane helix relative to the soluble domain varies among protomers.
Assignment of sequence register was straightforward and unambiguous owing to the relatively high resolution, almost completely ordered structure, and highfrequency bulky amino-acid side chains (σ 1 receptor is roughly 5% tryptophan). As a control for register assignment, the structure was built and register assigned in two independent ways. First it was manually built and register assigned by inspection of electron density. In parallel, sequence register was independently assigned automatically with phenix.autobuild, and results were confirmed to be identical throughout the entire polypeptide chain of each protomer. Representative composite omit map density is shown in Extended Data Fig. 2 . Ligands were manually placed into F o − F c difference maps (Extended Data Fig. 7 ). In the case of PD144418 the electron density was clear, and ligand position and pose were unambiguous. For 4-IBP, the pose was unambiguous owing to the high F o − F c peak resulting from the ligand iodine atom. After refinement, structure quality was assessed using MolProbity 36 , and figures were prepared in PyMOL 37 and UCSF Chimera 38 . All crystallographic data processing, refinement, and analysis software was compiled and supported by the SBGrid Consortium 39 . Sequence and structure conservation analysis. Sequence conservation analysis in Fig. 2 was computed using the ConSurf server 40 . In brief, a multiple sequence alignment of human σ 1 receptor to its closest 330 homologues was generated using a protein sequence BLAST search on the NCBI public database using the human wild-type σ 1 receptor protein sequence as query. These sequences were then used for ConSurf analysis, with conservation scores plotted using UCSF Chimera. Analysis of fold conservation was performed using the DALI server 41 with the PD144418-bound structure of the σ 1 receptor as query. Structures with Z-scores in excess of 8 were selected for further analysis, with results summarized in Extended Data Table 2 . Oligomerization analysis. The oligomeric state of σ 1 receptor was assessed by SEC-MALS using a Wyatt Dawn Heleos II multi-angle light scattering detector and Optilab TrEX refractive index monitor with an Agilent isocratic HPLC system. Receptor was prepared as described above, but with no ligand added during purification. The ligand-free receptor was diluted to 0.5 mg ml −1 in SEC-MALS buffer (0.025% n-dodecyl maltoside, 20 mM HEPES pH 7.5, 100 mM sodium chloride). Ligands were added to a final concentration of 25 μM to ensure stoichiometric excess over receptor and the sample was incubated with ligand at least 2 h at room temperature (21 °C). Separation steps were performed in SEC-MALS buffer with a Tosoh G4SWxl column at a flow rate of 0.5 ml min −1 . Data analysis used the Astra software package version 6.1.4.25 (Wyatt) using the protein conjugate method with previously reported dn/dc values for detergent 42 . The effect of ligands in LMNG/ CHS mixed micelle buffer was examined by analytical size exclusion in a similar procedure. The receptor was incubated with a twofold stoichiometric excess of the appropriate ligand and then subjected to SEC on a Superdex 200 column in a buffer consisting of 100 mM sodium chloride, 20 mM HEPES pH 7.5, 0.01% LMNG, 0.001% CHS, 1 μM ligand.
Oligomerization state was also assessed by native PAGE. For these experiments, 7.5 μg of σ 1 receptor was mixed with tenfold stoichiometric excess of SKF10,047 or NE-100 in a 10 μl reaction containing 20 mM HEPES pH 7.5, 250 mM NaCl, 0.1% MNG, 0.001% CHS. After incubation at room temperature for 1 h, the reaction was added to 1 μl loading buffer consisting of 50% glycerol and 0.25% (w/v) bromophenol blue and separated by 10% native PAGE running in Tris-glycine (pH 8.3) buffer supplemented with 0.5% CHAPS and 0.5% sodium cholate for 4 h at 150 V in an ice bath. Blue native PAGE was performed as previously described 43 . In brief, 10 μl reaction was supplemented with 1 μl of 50% glycerol and 1.5 μl of 0.1% Coomassie blue G-250 and was loaded onto a linear 3-12% gradient native PAGE gel (Life Technologies) running in blue cathode buffer supplemented with 0.05% MNG, 0.0005% CHS for 4 h at 150 V in an ice bath. The gel was stained using an InstantBlue staining kit (CBS Scientific). Radioligand binding. Radioligand binding experiments were performed similarly to established procedures 23 . In brief, Sf9 membranes expressing σ 1 receptor were prepared by dounce homogenization followed by centrifugation. Resuspended membranes were aliquoted and flash frozen before use. For each binding experiment, membranes were incubated with 3 H (+)-pentazocine (Perkin Elmer) at the indicated concentration or at a fixed concentration of 10 nM for competition binding assays. To approximate physiological conditions, incubation was performed at 37 °C for 2 h in 150 mM sodium chloride,
